
|Articles|May 1, 2003
Consider efficacy, effectiveness, safety to prove all-around value of a drug
Author(s)Mari Edlin
FMCP model urges plans to think outside the cost silo when making formulary decisions
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Eric Levine, M.P.H., on Medicaid work requirement exemptions and ADLs
2
New cholesterol guideline expands treatment eligibility to 55% of U.S. adults
3
FDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1
4
Acute pain drug Journavx helps drive Vertex growth in second quarter
5
























